Evidence map›Paper›PMID 35325204›Full record

ArticleMolecular biology and evolution2022

Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function.

Darren P Martin, Spyros Lytras, Alexander G Lucaci, Wolfgang Maier, Björn Grüning, Stephen D Shank, Steven Weaver, Oscar A MacLean, Richard J Orton, Philippe Lemey and 29 more

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors at 16 institutions in 6 countries.

Darren P MartinInstitute of Infectious Diseases and Molecular Medicine, Division of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-8785-0870
Spyros LytrasMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0003-4202-6682
Alexander G LucaciInstitute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA.
Wolfgang MaierBioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany, usegalaxy.eu.
Björn GrüningBioinformatics Group, Department of Computer Science, University of Freiburg, Freiburg, Germany, usegalaxy.eu.
Stephen D ShankInstitute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA.
Steven WeaverInstitute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA.
Oscar A MacLeanMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0003-4919-4697
Richard J OrtonMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0002-3389-4325
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
Maciej F BoniCenter for Infectious Disease Dynamics, Department of Biology, Pennsylvania State University, University Park, PA, USA.
Houriiyah TegallyKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Gordon W HarkinsSouth African National Bioinformatics Institute, University of the Western Cape, Cape Town, South Africa.
Cathrine ScheepersNational Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Jinal N BhimanNational Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Josie EverattNational Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Daniel G AmoakoNational Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
James Emmanuel SanKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Jennifer GiandhariKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Alex SigalAfrica Health Research Institute, Durban, South Africa.ORCID 0000-0001-8571-2004
NGS-SA
Carolyn WilliamsonInstitute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Nei-Yuan HsiaoDivision of Medical Virology, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa.
Anne von GottbergNational Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Arne De KlerkInstitute of Infectious Diseases and Molecular Medicine, Division of Computational Biology, Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa.
Robert W ShaferDivision of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA.
David L RobertsonMRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0001-6338-0221
Robert J WilkinsonWellcome Center for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa.
B Trevor SewellStructural Biology Research Unit, Department of Integrative Biomedical Sciences, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Richard LessellsKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Anton NekrutenkoDepartment of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, PA, USA, usegalaxy.org.ORCID 0000-0002-5987-8032
Allison J GreaneyBasic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Tyler N StarrBasic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Jesse D BloomBasic Sciences Division and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID 0000-0003-1267-3408
Ben MurrellDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Eduan WilkinsonKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Ravindra K GuptaAfrica Health Research Institute, Durban, South Africa.ORCID 0000-0001-9751-1808
Tulio de OliveiraKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.ORCID 0000-0002-3027-5254
Sergei L Kosakovsky PondInstitute for Genomics and Evolutionary Medicine, Department of Biology, Temple University, Philadelphia, PA, USA.ORCID 0000-0003-4817-4029
National Health Laboratory Service · ZAMRC University of Glasgow Centre for Virus Research · GBTemple University · USUniversity of Cape Town · ZAUniversity of KwaZulu-Natal · ZAHoward Hughes Medical Institute · USPennsylvania State University · USStellenbosch University · ZAUniversity of Freiburg · DEAfrica Health Research Institute · ZAKarolinska Institutet · SERega Institute for Medical Research · BEStanford University · USUniversity of Cambridge · GBUniversity of the Western Cape · ZAUniversity of Washington · US

Funding

Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Laura D. Hughes · 2018 to 2026
$32.0M
Turning big data analysis infrastructure for HIV researchR01AI134384 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI NEKRUTENKO, ANTON, POND, SERGEI L KOSAKOVSKY · 2017 to 2021
$4.2M
Statistical Innovation to Integrate Sequences and Phenotypes for Scalable Phylodynamic InferenceR01AI153044 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Marc A. Suchard · 2021 to 2026
$2.4M
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteinsR01AI141707 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BLOOM, JESSE D · 2018 to 2022
$2.1M
Cancer Research UK FC0010218Howard Hughes Medical InstituteMedical Research Council FC0010218Medical Research Council MC_PC_19026Medical Research Council MC_UU_12014/12NIAID NIH HHS R01 AI134384NIAID NIH HHS R01 AI141707NIAID NIH HHS R01 AI153044NIAID NIH HHS U19 AI135995Wellcome TrustWellcome Trust 203135Wellcome Trust 206298/Z/17/ZWellcome Trust 206369/Z/17/ZWellcome Trust 220977/Z/22/AWellcome Trust 222574/Z/21/ZWellcome Trust FC0010218
6 · The paper itself

Abstract

Among the 30 nonsynonymous nucleotide substitutions in the Omicron S-gene are 13 that have only rarely been seen in other SARS-CoV-2 sequences. These mutations cluster within three functionally important regions of the S-gene at sites that will likely impact (1) interactions between subunits of the Spike trimer and the predisposition of subunits to shift from down to up configurations, (2) interactions of Spike with ACE2 receptors, and (3) the priming of Spike for membrane fusion. We show here that, based on both the rarity of these 13 mutations in intrapatient sequencing reads and patterns of selection at the codon sites where the mutations occur in SARS-CoV-2 and related sarbecoviruses, prior to the emergence of Omicron the mutations would have been predicted to decrease the fitness of any virus within which they occurred. We further propose that the mutations in each of the three clusters therefore cooperatively interact to both mitigate their individual fitness costs, and, in combination with other mutations, adaptively alter the function of Spike. Given the evident epidemic growth advantages of Omicron overall previously known SARS-CoV-2 lineages, it is crucial to determine both how such complex and highly adaptive mutation constellations were assembled within the Omicron S-gene, and why, despite unprecedented global genomic surveillance efforts, the early stages of this assembly process went completely undetected.

Indexed as

COVID-19Spike Glycoprotein, CoronavirusHumansMutationSARS-CoV-2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2coevolutionepistasisnegative selectionpositive selection

Identifiers

PMID35325204
PMCPMC9037384
OpenAlexW4221027706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.